Find Didanosine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0INTERMEDIATES

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

186 RELATED EXCIPIENT COMPANIES

310EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as:
Molecular Formula
C10H12N4O3
Molecular Weight
236.23  g/mol
InChI Key
BXZVVICBKDXVGW-NKWVEPMBSA-N

Didanosine
1 2D Structure

Didanosine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
2.1.2 InChI
InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1
2.1.3 InChI Key
BXZVVICBKDXVGW-NKWVEPMBSA-N
2.1.4 Canonical SMILES
C1CC(OC1CO)N2C=NC3=C2NC=NC3=O
2.1.5 Isomeric SMILES
C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O
2.2 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 236.23 g/mol
Molecular Formula C10H12N4O3
XLogP3-1.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass236.09094026 g/mol
Monoisotopic Mass236.09094026 g/mol
Topological Polar Surface Area88.7 A^2
Heavy Atom Count17
Formal Charge0
Complexity348
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 6  
Drug NameDidanosine
Drug LabelDidanosine delayed-release capsules are an enteric-coated formulation of didanosine, (ddl), a synthetic purine nucleoside analogue active against the Human Immunodeficiency Virus (HIV). Didanosine delayed-release capsules, containing enteric-coated p...
Active IngredientDidanosine
Dosage FormCapsule, delayed rel pellets; Tablet, for suspension; For solution
RouteOral
Strength200mg; 250mg; 100mg; 125mg; 150mg; 10mg/ml; 400mg
Market StatusPrescription
CompanyMylan Pharms; Aurobindo; Aurobindo Pharma; Barr

2 of 6  
Drug NameVidex
PubMed HealthDidanosine (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelVIDEX is a brand name for didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. Didanosine is available as VIDEX, a Pediatric Powder for Oral Solution [see How Supplied/Storage and Handling (16)] and as VIDEX EC Delayed-Re...
Active IngredientDidanosine
Dosage FormFor solution
RouteOral
Strength10mg/ml
Market StatusPrescription
CompanyBristol Myers Squibb

3 of 6  
Drug NameVidex ec
PubMed HealthDidanosine (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelVIDEX EC is the brand name for an enteric-coated formulation of didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. VIDEX EC Delayed-Release Capsules, containing enteric-coated beadlets, are available for oral administrati...
Active IngredientDidanosine
Dosage FormCapsule, delayed rel pellets
RouteOral
Strength200mg; 250mg; 125mg; 400mg
Market StatusPrescription
CompanyBristol Myers Squibb

4 of 6  
Drug NameDidanosine
Drug LabelDidanosine delayed-release capsules are an enteric-coated formulation of didanosine, (ddl), a synthetic purine nucleoside analogue active against the Human Immunodeficiency Virus (HIV). Didanosine delayed-release capsules, containing enteric-coated p...
Active IngredientDidanosine
Dosage FormCapsule, delayed rel pellets; Tablet, for suspension; For solution
RouteOral
Strength200mg; 250mg; 100mg; 125mg; 150mg; 10mg/ml; 400mg
Market StatusPrescription
CompanyMylan Pharms; Aurobindo; Aurobindo Pharma; Barr

5 of 6  
Drug NameVidex
PubMed HealthDidanosine (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelVIDEX is a brand name for didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. Didanosine is available as VIDEX, a Pediatric Powder for Oral Solution [see How Supplied/Storage and Handling (16)] and as VIDEX EC Delayed-Re...
Active IngredientDidanosine
Dosage FormFor solution
RouteOral
Strength10mg/ml
Market StatusPrescription
CompanyBristol Myers Squibb

6 of 6  
Drug NameVidex ec
PubMed HealthDidanosine (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelVIDEX EC is the brand name for an enteric-coated formulation of didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. VIDEX EC Delayed-Release Capsules, containing enteric-coated beadlets, are available for oral administrati...
Active IngredientDidanosine
Dosage FormCapsule, delayed rel pellets
RouteOral
Strength200mg; 250mg; 125mg; 400mg
Market StatusPrescription
CompanyBristol Myers Squibb

USDMF

read-more
read-more

01

Ajinomoto Co Inc

Japan

USDMF

arrow
BIO Partnering at JPM
Not Confirmed

02

BIO Partnering at JPM
Not Confirmed

02

BIO Partnering at JPM
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 23635

Submission : 2010-04-16

Status : Inactive

Type : II

blank

03

BIO Partnering at JPM
Not Confirmed

04

BIO Partnering at JPM
Not Confirmed

05

Cipla Ltd

India

USDMF

arrow
BIO Partnering at JPM
Not Confirmed

05

Cipla Ltd

India
arrow
BIO Partnering at JPM
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 19784

Submission : 2008-11-13

Status : Inactive

Type : II

blank

06

Raylo Chemicals

U.S.A

USDMF

arrow
BIO Partnering at JPM
Not Confirmed

06

BIO Partnering at JPM
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 7680

Submission : 1988-09-23

Status : Inactive

Type : II

blank

07

Hetero Labs Ltd

India

USDMF

arrow
BIO Partnering at JPM
Not Confirmed

07

BIO Partnering at JPM
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 18733

Submission : 2005-09-07

Status : Inactive

Type : II

blank

08

Signa Sa De Cv

Mexico

USDMF

arrow
BIO Partnering at JPM
Not Confirmed

08

BIO Partnering at JPM
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 17413

Submission : 2004-05-26

Status : Inactive

Type : II

blank

09

BIO Partnering at JPM
Not Confirmed

09

BIO Partnering at JPM
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 21215

Submission : 2007-12-21

Status : Active

Type : II

blank

10

BIO Partnering at JPM
Not Confirmed

10

BIO Partnering at JPM
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 8017

Submission : 1989-04-08

Status : Inactive

Type : II

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - FOR SOLUTION;ORAL - 10MG/ML

USFDA APPLICATION NUMBER - 20156

read-more

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21183

read-more

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21183

read-more

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21183

read-more

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21183

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Controlled & Modified Release

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Solubilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Taste Masking

read-more
read-more

Topical

read-more
read-more

Empty Capsules

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Rheology Modifiers

read-more
read-more

Coloring Agents

read-more
read-more

Emulsifying Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Finished Drug Prices

read-more
read-more

01

Brand Name : DIDANOSINE

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Brand Name : DIDANOSINE

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Didanosine

Dosage Form : CAPSULE, DELAYED REL PELLETS;ORA...

Dosage Strength : 200MG

Price Per Pack :

Published in :

Country : USA

RX/OTC/DISCN : DISCN

blank

02

Brand Name : DIDANOSINE

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Brand Name : DIDANOSINE

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Didanosine

Dosage Form : CAPSULE, DELAYED REL PELLETS;ORA...

Dosage Strength : 250MG

Price Per Pack :

Published in :

Country : USA

RX/OTC/DISCN : DISCN

blank

03

Brand Name : DIDANOSINE

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Brand Name : DIDANOSINE

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Didanosine

Dosage Form : CAPSULE, DELAYED REL PELLETS;ORA...

Dosage Strength : 400MG

Price Per Pack :

Published in :

Country : USA

RX/OTC/DISCN : DISCN

blank

04

Brand Name : Videx

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Brand Name : Videx

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Didanosine

Dosage Form : Didanosine 125Mg 30 Joined' Oral...

Dosage Strength : 30 cps gastrores 125 mg

Price Per Pack (Euro) : 73.52

Published in :

Country : Italy

RX/OTC/DISCN : Class H

blank

05

Brand Name : Videx

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Brand Name : Videx

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Didanosine

Dosage Form : Didanosine 2.000Mg 1 Combined Or...

Dosage Strength : 1 bottle os groun soluz 2 g

Price Per Pack (Euro) : 37.47

Published in :

Country : Italy

RX/OTC/DISCN : Class H

blank

06

Brand Name : Videx

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Brand Name : Videx

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Didanosine

Dosage Form : Didanosine 200Mg 30 Joined' Oral...

Dosage Strength : 30 cps gastrores 200 mg

Price Per Pack (Euro) : 117.62

Published in :

Country : Italy

RX/OTC/DISCN : Class H

blank

07

Brand Name : Videx

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Brand Name : Videx

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Didanosine

Dosage Form : Didanosine 250Mg 30 Joined' Oral...

Dosage Strength : 30 cps gastrores 250 mg

Price Per Pack (Euro) : 147.01

Published in :

Country : Italy

RX/OTC/DISCN : Class H

blank

08

Brand Name : Videx

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Brand Name : Videx

U.S.A
arrow
BIO Partnering at JPM
Not Confirmed

Didanosine

Dosage Form : Didanosine 400Mg 30 Joined' Oral...

Dosage Strength : 30 cps gastrores 400 mg

Price Per Pack (Euro) : 235.22

Published in :

Country : Italy

RX/OTC/DISCN : Class H

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Didanosine Manufacturers

A Didanosine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Didanosine, including repackagers and relabelers. The FDA regulates Didanosine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Didanosine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Didanosine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Didanosine Suppliers

A Didanosine supplier is an individual or a company that provides Didanosine active pharmaceutical ingredient (API) or Didanosine finished formulations upon request. The Didanosine suppliers may include Didanosine API manufacturers, exporters, distributors and traders.

click here to find a list of Didanosine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Didanosine USDMF

A Didanosine DMF (Drug Master File) is a document detailing the whole manufacturing process of Didanosine active pharmaceutical ingredient (API) in detail. Different forms of Didanosine DMFs exist exist since differing nations have different regulations, such as Didanosine USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Didanosine DMF submitted to regulatory agencies in the US is known as a USDMF. Didanosine USDMF includes data on Didanosine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Didanosine USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Didanosine suppliers with USDMF on PharmaCompass.

Didanosine CEP

A Didanosine CEP of the European Pharmacopoeia monograph is often referred to as a Didanosine Certificate of Suitability (COS). The purpose of a Didanosine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Didanosine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Didanosine to their clients by showing that a Didanosine CEP has been issued for it. The manufacturer submits a Didanosine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Didanosine CEP holder for the record. Additionally, the data presented in the Didanosine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Didanosine DMF.

A Didanosine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Didanosine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Didanosine suppliers with CEP (COS) on PharmaCompass.

Didanosine WC

A Didanosine written confirmation (Didanosine WC) is an official document issued by a regulatory agency to a Didanosine manufacturer, verifying that the manufacturing facility of a Didanosine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Didanosine APIs or Didanosine finished pharmaceutical products to another nation, regulatory agencies frequently require a Didanosine WC (written confirmation) as part of the regulatory process.

click here to find a list of Didanosine suppliers with Written Confirmation (WC) on PharmaCompass.

Didanosine NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Didanosine as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Didanosine API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Didanosine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Didanosine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Didanosine NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Didanosine suppliers with NDC on PharmaCompass.

Didanosine GMP

Didanosine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Didanosine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Didanosine GMP manufacturer or Didanosine GMP API supplier for your needs.

Didanosine CoA

A Didanosine CoA (Certificate of Analysis) is a formal document that attests to Didanosine's compliance with Didanosine specifications and serves as a tool for batch-level quality control.

Didanosine CoA mostly includes findings from lab analyses of a specific batch. For each Didanosine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Didanosine may be tested according to a variety of international standards, such as European Pharmacopoeia (Didanosine EP), Didanosine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Didanosine USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty